New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 25, 2013
06:53 EDTTHRXTheravance upgraded to Outperform from Market Perform at Bernstein
Bernstein upgraded Theravance and views risk/reward as favorable ahead of Relvar and Anoro FDA/EMA decisions this year. Price target is $26.
News For THRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 17, 2014
05:25 EDTTHRXTheravance announces positive Anoro Ellipta study data published
Subscribe for More Information
October 9, 2014
16:09 EDTTHRXTheravance names Eric d'Esparbes as CFO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use